Correlation Between Vincerx Pharma and Instil Bio
Can any of the company-specific risk be diversified away by investing in both Vincerx Pharma and Instil Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vincerx Pharma and Instil Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vincerx Pharma and Instil Bio, you can compare the effects of market volatilities on Vincerx Pharma and Instil Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vincerx Pharma with a short position of Instil Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vincerx Pharma and Instil Bio.
Diversification Opportunities for Vincerx Pharma and Instil Bio
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Vincerx and Instil is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Vincerx Pharma and Instil Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Instil Bio and Vincerx Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vincerx Pharma are associated (or correlated) with Instil Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Instil Bio has no effect on the direction of Vincerx Pharma i.e., Vincerx Pharma and Instil Bio go up and down completely randomly.
Pair Corralation between Vincerx Pharma and Instil Bio
Given the investment horizon of 90 days Vincerx Pharma is expected to under-perform the Instil Bio. In addition to that, Vincerx Pharma is 1.16 times more volatile than Instil Bio. It trades about 0.0 of its total potential returns per unit of risk. Instil Bio is currently generating about 0.06 per unit of volatility. If you would invest 1,180 in Instil Bio on August 31, 2024 and sell it today you would earn a total of 1,511 from holding Instil Bio or generate 128.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vincerx Pharma vs. Instil Bio
Performance |
| Timeline |
| Vincerx Pharma |
| Instil Bio |
Vincerx Pharma and Instil Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vincerx Pharma and Instil Bio
The main advantage of trading using opposite Vincerx Pharma and Instil Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vincerx Pharma position performs unexpectedly, Instil Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Instil Bio will offset losses from the drop in Instil Bio's long position.| Vincerx Pharma vs. Cue Biopharma | Vincerx Pharma vs. Eliem Therapeutics | Vincerx Pharma vs. Inhibrx | Vincerx Pharma vs. Molecular Partners AG |
| Instil Bio vs. Assembly Biosciences | Instil Bio vs. Nuvation Bio | Instil Bio vs. Achilles Therapeutics PLC | Instil Bio vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |